Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05224193
Other study ID # RHM CHI1102
Secondary ID 301029
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2021
Est. completion date September 1, 2026

Study information

Verified date February 2022
Source University Hospital Southampton NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Assessment of physical activity on children with Inflammatory Bowel Disease using questionnaires and wrist watch based activity monitors. The participants will be recruited from paediatric IBD clinics and will undergo questionnaires to assess their activity level, disease activity and quality of life scores. The participants will then be invited to wear a wrist based accelerometer for a week. The participants will complete a physical activity diary, food diary and stool chart at the same time. Results will be analysed to see the level of physical activity and assess if the participants are meeting the recommended level of physical activity


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date September 1, 2026
Est. primary completion date April 1, 2022
Accepts healthy volunteers No
Gender All
Age group 6 Years to 18 Years
Eligibility Inclusion Criteria: - Children/adolescents from age of 6 to 18 years of age - Confirmed endoscopic/histology based IBD diagnosis - Under the care of the Southampton University Hospitals NHS Foundation Trust paediatric gastroenterology team - Able to provide consent / assent to participate in the study - Able to understand and/or cooperate with the study requirements - Pregnant participants will be included as long as they can complete the physical assessmentsExclusion Criteria:

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom Univeristy Hospital Southampton Southampton Hampshire

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Southampton NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Quality of Life Score Paediatric Quality of Life Score - PEDSQL scored in psychosocial and physical sections. Both are scored out of 100 and the higher the score the better health related quality of life. At baseline clinic assessment
Primary Moderate Vigorous Physical Activity measurement Amount of time spent performing moderate and vigorous physical activity Over 1 Week
Primary Sedentary time Amount of time spent sedentary 1 week
Secondary Disease Activity Disease activity scores using either PUCAI (/85) or PCDAI (/100). Higher scores indicate more active disease At Baseline Clinical Assessment
Secondary Perceived Physical Activity Youth Physical Activity Scale - Subjective Assessment of Moderate Vigorous Physical Activity in Hours over a 1 week retrospective period At Baseline Clinical Assessment
Secondary Amount and Quality of Sleep Child Sleep Health Questionnaire scored out of 154 total and is parent/ carer subjective sleep assessment. Scored in four separate domains. Higher scores indicate increased duration and quality of sleep At Baseline Clinical Assessment
Secondary Nutritional Assessment Mid Upper Arm Circumference At Baseline Clinical Assessment
Secondary Growth Assessment Height in meters At Baseline Clinical Assessment
Secondary Growth Assessment Weight in kg At Baseline Clinical Assessment
Secondary Nutrition Assessment 3 day self-reported food diary 3 day assessment after baseline visit
Secondary Amount and Quality of Sleep Accelerometer measured sleep 1 week period
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04046913 - The ADDapt Diet in Reducing Crohn's Disease Inflammation N/A
Active, not recruiting NCT04989907 - A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Active, not recruiting NCT04990258 - A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
Completed NCT06216223 - Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients N/A
Enrolling by invitation NCT06015789 - Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
Recruiting NCT06065995 - StoMakker Mobile Application N/A
Recruiting NCT03282786 - Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease N/A
Recruiting NCT06002074 - SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases N/A
Recruiting NCT04960826 - Study of an Environmental Risk Factor in Crohn's Disease
Recruiting NCT05413941 - Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease N/A
Completed NCT03668249 - A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
Completed NCT00721812 - A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 Phase 1
Recruiting NCT05809999 - IBD Neoplasia Surveillance RCT N/A
Recruiting NCT04138225 - The Ecological Role of Yeasts in the Human Gut
Recruiting NCT04991324 - Cholecalciferol Comedication in IBD - the 5C-study Phase 3
Completed NCT03173144 - Chronic Inflammatory Disease, Lifestyle and Treatment Response
Not yet recruiting NCT05043818 - A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression
Recruiting NCT03042091 - Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery Early Phase 1
Completed NCT02874365 - Intestinal Stem Cells Characterization N/A